or Try an Advanced Search...

    Technical Analysis for FH - Filament Health Corp

    Grade Last Price % Change Price Change
    F 0.045 12.50% 0.005
    FH closed up 12.5 percent on Thursday, September 19, 2024, on 5 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical FH trend table...
    Date Alert Name Type % Chg
    MACD Bullish Signal Line Cross Bullish 0.00%
    Fell Below 20 DMA Bearish 12.50%
    Fell Below 50 DMA Bearish 12.50%
    MACD Bearish Signal Line Cross Bearish 12.50%
    180 Bearish Setup Bearish Swing Setup 12.50%
    Wide Bands Range Expansion 12.50%
    Gapped Down Weakness 12.50%
    20 DMA Support Bullish -10.00%
    50 DMA Support Bullish -10.00%
    Stochastic Reached Overbought Strength -10.00%
    Older End-of-Day Signals for FH ...

       Recent Intraday Alerts

    Alert Time
    Gapped Down (Full) 3 days ago
    Down 5% 3 days ago
    Down 3% 3 days ago
    Down 2% 3 days ago
    Down 1% 3 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    FH Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. Its leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. The company also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, it provides in-house human clinical trials, as well as license technology to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Entheogens Drug Development Ayahuasca Drug Discovery Serotonin Receptor Agonists

    Is FH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.2
    52 Week Low 0.03
    Average Volume 72,950
    200-Day Moving Average 0.071
    50-Day Moving Average 0.049
    20-Day Moving Average 0.046
    10-Day Moving Average 0.045
    Average True Range 0.006
    RSI (14) 48.19
    ADX 18.65
    +DI 28.849
    -DI 21.091
    Chandelier Exit (Long, 3 ATRs) 0.047
    Chandelier Exit (Short, 3 ATRs) 0.058
    Upper Bollinger Bands 0.056
    Lower Bollinger Band 0.037
    Percent B (%b) 0.43
    BandWidth 40.605
    MACD Line -0.002
    MACD Signal Line -0.002
    MACD Histogram 0.0
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.053
    Resistance 3 (R3) 0.052 0.048 0.051
    Resistance 2 (R2) 0.048 0.046 0.049 0.051
    Resistance 1 (R1) 0.047 0.045 0.048 0.048 0.050
    Pivot Point 0.043 0.043 0.044 0.044 0.043
    Support 1 (S1) 0.042 0.041 0.043 0.043 0.040
    Support 2 (S2) 0.038 0.040 0.039 0.039
    Support 3 (S3) 0.037 0.038 0.039
    Support 4 (S4) 0.038